Harnessing the power of natural killer cells in Lymphoma immunotherapy: Overcoming challenges and enhancing treatment options
Elham Roshandel, Maryam Vahdat Lasemi, Maryam Mehravar, Maryam Salimi, Mohammad Majidi, Fatemeh Mohammadali, Hamide Rahmani Seraji, Abbas Hajifathali · 2026
Read Harnessing the power of natural killer cells in Lymphoma immunotherapy: Overcoming challenges and enhancing treatment options by Elham Roshandel, Maryam Vahdat Lasemi, Maryam Mehravar, Maryam Salimi, Mohammad Majidi, Fatemeh Mohammadali, Hamide Rahmani Seraji, Abbas Hajifathali (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13156988.txt.
Description
Elham Roshandel and seven co-authors review natural killer cell therapy as a rising option for lymphoma. These immune cells kill tumors fast and without prior sensitization, a rare mix. The tumor setting can still blunt them through immune escape tricks. The review sorts the main formats: donor or self cell infusions, CAR-engineered killer cells, and combinations with standard drugs.
Donor cell transplants showed promise in some lymphoma subtypes, with lower graft-versus-host risk and longer remissions. Pairing the cells with chemotherapy or checkpoint inhibitors may add synergy. Cell persistence, the suppressive tumor setting, and delivery remain the hurdles to clear.
Catalog record
| CREATOR | Elham Roshandel, Maryam Vahdat Lasemi, Maryam Mehravar, Maryam Salimi, Mohammad Majidi, Fatemeh Mohammadali, Hamide Rahmani Seraji, Abbas Hajifathali |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 47 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |